TMEM45A inhibitors belong to a unique class of chemical compounds designed to specifically target and inhibit the function of the TMEM45A protein. TMEM45A, or Transmembrane Protein 45A, is a relatively less characterized member of the transmembrane protein family. These proteins are known for their roles in various cellular processes, including cellular transport, signal transduction, and cellular interactions. TMEM45A is characterized by its transmembrane domains, which allow it to span the cell membrane and play a role in intracellular and intercellular communication and transport processes. The exact biological function of TMEM45A is not fully understood, but it is believed to be involved in cellular homeostasis and possibly in the regulation of specific cellular pathways. The development of TMEM45A inhibitors focuses on targeting this protein to modulate its suspected functions and study its role in cellular processes more comprehensively.
The process of designing TMEM45A inhibitors is challenging due to the relatively limited understanding of the protein's structure and function. This development requires a multi-disciplinary approach, encompassing biochemistry, molecular biology, and pharmacology. Initial steps often involve detailed studies to elucidate the protein's structure, particularly its transmembrane regions. Advanced techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy are employed to gain insights into the three-dimensional configuration of TMEM45A, which is essential for identifying inhibitor binding sites. In parallel, computational methods play a crucial role in the development process. Molecular modeling and docking simulations are used to predict how various chemical compounds might interact with TMEM45A, focusing on those that can bind to the protein and inhibit its function. These predictions guide the synthesis of compounds, which are then subjected to biochemical and cellular assays to test their efficacy and specificity as TMEM45A inhibitors. The development of TMEM45A inhibitors is an iterative and exploratory process, advancing with ongoing research that contributes to understanding the biological role of TMEM45A and the implications of modulating its activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
A compound that intercalates into DNA, inhibiting RNA polymerase and thus potentially suppressing gene expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
A topoisomerase I inhibitor, preventing DNA from uncoiling, which is necessary for transcription, potentially reducing gene expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
A compound that can intercalate into DNA, which may alter gene expression by inhibiting DNA and RNA polymerase activity. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
A diterpene triepoxide that has been shown to inhibit the transcription of a wide range of genes, potentially including TMEM45A. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
A chemical inhibitor of RNA synthesis, potentially reducing mRNA levels of various genes. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
A potent inhibitor of RNA polymerase II, which is involved in mRNA synthesis, potentially lowering gene expression levels. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
A cyclin-dependent kinase inhibitor that can alter cell cycle progression and therefore may affect gene expression. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
An adenosine analog that can terminate mRNA synthesis prematurely, potentially reducing gene expression. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
An inhibitor of DNA polymerase, which can suppress replication and, consequently, gene expression. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
A compound that inhibits bacterial RNA polymerase; in eukaryotes, it can potentially affect mitochondrial RNA polymerase. | ||||||